DYN stock news · Dyne Therapeutics

Stories about Dyne Therapeutics (DYN) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for DYN

Follow Dyne Therapeutics (DYN) free. When we publish a story about it, you get the plain-English explanation as an alert.

Free on the App Store and Google Play, or on the web.

Oct 9, 2026, 8:20 AM ET · Market
12 health care stocks are changing a lot before the market opens on Friday.
Neutral
Dyne Therapeutics shares rose 9.9% in the pre-market list. The article gives no company news explaining the move, so it does not change the business outlook.
Sep 29, 2026, 4:17 PM ET · Market
Dyne Therapeutics shares new clinical results from its ACHIEVE trial.
Good for DYN
Dyne reported improvements across several health measures in its drug study. The results are encouraging, but most participants did not receive the planned dose throughout the year, and a larger study update is still pending.